Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC/CBD capsules for prevention of chemotherapy-induced nausea and vomiting
ACTRN12616001036404Phase 3Terminated
- Sponsor
- University of Sydney
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dronabinol and cannabidiol in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Sydney. Started Dec 2016; status: terminated.
02
Drugs
dronabinolcannabidiol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ACTRN12616001036404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001036404.